Nigerian-born doctor wins ‘brain tumor research’ award in US – Independent Observers

Nigerian-born doctor wins ‘brain tumor research’ award in US

147 0

By Kunle Adedoyin

Chibawanye Ene, a Nigerian-born medical doctor based in USA, has won the 2019 Ronald L. Bittner Award on brain tumor research.

Ene, who received the award at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting which held from April 13 to April 17 in San Diego, US, won the award with his research work titled: “Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in Glioblastoma.”

Glioblastoma is an aggressive form of cancer that can occur in the brain or spinal cord with symptoms ranging from headaches to personality changes, nausea, and incontinence.

Immunotherapy is a type of cancer treatment that helps immune system fight cancer, although it has been largely unsuccessful in the treatment of Glioblastoma.

The Applied Radiation Oncology, a quarterly journal on cancer, who reported the awards, stated that the molecular structure of the tumor found in that form of cancer only allows few of the cancerous cells to be eliminated during treatment.

The new findings in Ene’s research have shown promise for better treatment options, revealing that “radiation combined with Anti PD L1 therapy induces an immunological response to unirradiated glioblastoma.”

“The researchers are currently optimizing other treatment combinations that could also be readily assessed in phase I human clinical trials,” the journal said.

The Ronald L. Bittner Award, which was endowed by E. Laurie Bittner in memory of her husband, is given out yearly for the best abstract paper on brain tumor research submitted by a resident doctor or junior faculty member in the US. Ene, 37, hails from Akpugo in Nkanu west local government area of Enugu State.   

Related Post

AU congratulates Buhari

Posted by - March 1, 2019 0
By Tunde Niyi-Akinmade The African Union (AU) has congratulated President Muhammadu Buhari on his re-election in the February 23 presidential…

Leave a comment

Your email address will not be published. Required fields are marked *